We are live on ! Find out more
MNPR icon

Monopar Therapeutics
MNPR

43 hedge funds and large institutions have $113M invested in Monopar Therapeutics in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 4

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

23% more funds holding

Funds holding: 35 → 43 (+8)

4.63% more ownership

Funds ownership: 47.31% → 51.94% (+4.6%)

4% more capital invested

Capital invested by funds: $109M → $113M (+$3.93M)

Holders
43
Holders Change
+8
Holders Change %
+22.86%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
15
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.93M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.76M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$1.38M
4
ABG
Ally Bridge Group
New York
+$1.25M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.14M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.33M
2
Millennium Management
Millennium Management
New York
-$1.66M
3
Marshall Wace
Marshall Wace
United Kingdom
-$946K
4
Goldman Sachs
Goldman Sachs
New York
-$673K
5
Jane Street
Jane Street
New York
-$377K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$82.3K +$74.5K +2,051 +820%
Mirae Asset Global ETFs Holdings
27
Mirae Asset Global ETFs Holdings
Hong Kong
$79.5K +$80.7K +2,222 New
Bank of America
28
Bank of America
North Carolina
$75.5K -$13.4K -369 -15%
JP Morgan Chase
29
JP Morgan Chase
New York
$68.7K +$66.1K +1,821 +1,821%
A
30
AlphaQuest
New York
$63.8K +$20.7K +569 +47%
Citigroup
31
Citigroup
New York
$51.6K +$44.2K +1,218 +541%
PFSRSONJ
32
Police & Firemen's Retirement System of New Jersey
New Jersey
$34.5K +$35K +964 New
NA
33
NewEdge Advisors
Louisiana
$21.5K – – –
Legal & General Group
34
Legal & General Group
United Kingdom
$16K +$16.5K +453 New
Raymond James Financial
35
Raymond James Financial
Florida
$15.4K +$15.7K +431 New
AIP
36
Ameritas Investment Partners
Nebraska
$14.8K +$15.1K +415 New
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$12.4K +$12.6K +347 New
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$9.09K +$9.22K +254 New
AB
39
Amalgamated Bank
New York
$5K +$5.05K +139 New
AF
40
Allworth Financial
California
$3.58K – – –
Fidelity Investments
41
Fidelity Investments
Massachusetts
$1.11K +$1.13K +31 New
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$1K -$6.75K -186 -91%
SCM
43
Sterling Capital Management
North Carolina
$358 +$363 +10 New
Marshall Wace
44
Marshall Wace
United Kingdom
– -$946K -25,988 Closed
Goldman Sachs
45
Goldman Sachs
New York
– -$673K -18,480 Closed
Jane Street
46
Jane Street
New York
– -$377K -10,357 Closed
OAC
47
OMERS Administration Corp
Ontario, Canada
– -$328K -9,000 Closed
HF
48
HRT Financial
New York
– -$299K -8,228 Closed
Balyasny Asset Management
49
Balyasny Asset Management
Illinois
– -$224K -6,141 Closed
IC
50
Ikarian Capital
Texas
– -$215K -5,908 Closed
1
2
3

MNPR Hedge Fund Activity: Q2 2025 in Review

43 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Monopar Therapeutics (MNPR) for Q2 2025, worth a combined $113M — up 3.6% from $109M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new MNPR positions and 11 closed out — a net gain of 8 holders — while 15 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $6.93M. The largest seller was Point72 Asset Management, cutting an estimated $2.33M.

  • 43 institutional investors held Monopar Therapeutics (MNPR) as of Q2 2025, up from 35 in Q1 2025.
  • Funds reported $113M of Monopar Therapeutics stock for Q2 2025, up 3.6% quarter-over-quarter.
  • 19 funds opened new Monopar Therapeutics positions in Q2 2025 and 11 closed out, a net change of +8 holders.
  • The largest Monopar Therapeutics buyer in Q2 2025 was BlackRock, an estimated $6.93M added.
  • The largest Monopar Therapeutics seller in Q2 2025 was Point72 Asset Management, an estimated $2.33M sold.

Based on aggregated 13F filings for Q2 2025.